Although the relevance of these findings has been sometimes limited by the assay design, size or length, overall the randomized controlled trials have shown a decrease in serum PSA as well as a decreased progression rate in men with prostate cancer treated with tea phytochemicals [353,354,355]. The gene discussed is KLK3; the disease is prostate carcinoma.